Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (61-70 of 223) with videos related to

Pageof 23
Sort By:
Pediatric Blood & Cancer|November 2, 2017
Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemiaChristiane Walter, Christian Pozzorini, Katarina Reinhardt, et al.
Journal of Cancer Research and Clinical Oncology|October 12, 2022
Physical activity in 9-15 year-old pediatric cancer survivors compared to a nationwide sampleMiriam Götte, Simon Basteck, Ronja Beller, et al.
Blood|April 14, 2007
Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expressionStefan Gattenloehner, Sergei Chuvpilo, Claudia Langebrake, et al.
Cancers|October 13, 2021
Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid LeukemiaLina Marie Hoffmeister, Eser Orhan, Christiane Walter, et al.
BMC Cancer|April 14, 2025
The impact of a single HIIT intervention on the mobilization of NK cells and ILCs in adolescents and young adults (AYA) undergoing cancer treatment: an interventional controlled trialIsabella Deppe, Ronja Beller, Fabian Kiehl, et al.
International Journal of Cancer|July 21, 2012
Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cellsBasant Kumar Thakur, Tino Dittrich, Prakash Chandra, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2004
Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cellsUlrike Puhlmann, Christina Ziemann, Gudrun Ruedell, et al.
Haematologica|October 18, 2006
A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemiaBianca F Goemans, Christian M Zwaan, Dirk Reinhardt, et al.
Pediatric Blood & Cancer|June 3, 2025
Effects of a Low Versus Moderate-High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo-HSCT-The ANIMAL Exploratory Randomized Controlled TrialRonja Beller, Sabrina B Bennstein, Dirk Reinhardt, et al.
Annals of Hematology|April 28, 2015
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialJana Schweitzer, Martin Zimmermann, Mareike Rasche, et al.
Pageof 23

Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
Pediatric Blood & Cancer|November 2, 2017
Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemiaChristiane Walter, Christian Pozzorini, Katarina Reinhardt, et al.
Journal of Cancer Research and Clinical Oncology|October 12, 2022
Physical activity in 9-15 year-old pediatric cancer survivors compared to a nationwide sampleMiriam Götte, Simon Basteck, Ronja Beller, et al.
Blood|April 14, 2007
Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expressionStefan Gattenloehner, Sergei Chuvpilo, Claudia Langebrake, et al.
Cancers|October 13, 2021
Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid LeukemiaLina Marie Hoffmeister, Eser Orhan, Christiane Walter, et al.
BMC Cancer|April 14, 2025
The impact of a single HIIT intervention on the mobilization of NK cells and ILCs in adolescents and young adults (AYA) undergoing cancer treatment: an interventional controlled trialIsabella Deppe, Ronja Beller, Fabian Kiehl, et al.
International Journal of Cancer|July 21, 2012
Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cellsBasant Kumar Thakur, Tino Dittrich, Prakash Chandra, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 27, 2004
Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cellsUlrike Puhlmann, Christina Ziemann, Gudrun Ruedell, et al.
Haematologica|October 18, 2006
A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemiaBianca F Goemans, Christian M Zwaan, Dirk Reinhardt, et al.
Pediatric Blood & Cancer|June 3, 2025
Effects of a Low Versus Moderate-High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo-HSCT-The ANIMAL Exploratory Randomized Controlled TrialRonja Beller, Sabrina B Bennstein, Dirk Reinhardt, et al.
Annals of Hematology|April 28, 2015
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialJana Schweitzer, Martin Zimmermann, Mareike Rasche, et al.
Pageof 23